Home - Melanoma Research Alliance

MRA 2019-2020 Request for Proposals - Now Available

The Melanoma Research Alliance (MRA) is pleased to announce its 2019 – 2020 Request for Proposals for preclinical, translational and early clinical research with the power to transform melanoma prevention, detection, staging, and treatment.

The 2018 - 2019 award cycle is anticipated to support at least $9 million in funding. Proposals will be accepted for Pilot, Team Science, Young Investigator, and Mid-Career Awards.

Acral Melanoma & Adjuvant Therapy – One Patient’s Decision

When David was diagnosed with Stage 3 acral melanoma he faced a major decision. The surgery to remove it was successful - but should he move forward with adjuvant therapy to reduce the risk of it returning? Learn more about the benefits - and risks - of this approach and read what David decided.

Treating Melanoma Patients Before Surgery

Over 90% of patients who have their tumors surgically removed will never see their tumors come back or spread to other sites, but is there a way to prevent recurrence in those patients that will eventually go on to relapse? One approach currently being tested in clinical trials, termed neoadjuvant therapy, is to treat early stage patients with targeted or immunotherapy before surgical removal of their tumor.

Take Control After a Melanoma Diagnosis

While there are many things you can't control when it comes to melanoma, such as treatment side effects, there is a lot you can and should be proactive about, including finding the information you need, identifying a clinical trial if appropriate, expressing your wishes and values in regards to your treatment, and managing your supportive team of caregivers and family members.